Efficacy of Contrast-Enhanced Cone-Beam Breast CT in Assessing NAC Involvement
Overview
This study evaluated the diagnostic performance of contrast-enhanced cone-beam breast CT (CE-CBBCT) for preoperative assessment of nipple–areolar complex (NAC) involvement in early breast cancer. Using propensity score-matched cases, CE-CBBCT demonstrated promising accuracy in identifying NAC involvement, potentially aiding surgical decision-making for nipple-sparing mastectomy.
Background
Nipple-sparing mastectomy (NSM) preserves the nipple–areola complex (NAC) and skin while removing breast glandular tissue, addressing patients' psychological needs. However, NAC involvement occurs in 8% to 27.7% of breast cancer cases and is a contraindication for NSM. Accurate preoperative evaluation of NAC involvement is essential. Conventional imaging modalities such as mammography, ultrasound, MRI, and PET/CT have shown variable accuracy (80.8%–87.4%) and sensitivity (60.5%–92%) in predicting NAC involvement. CE-CBBCT is a novel imaging technique offering rapid, non-compressive, high-resolution 3D breast imaging with contrast enhancement, but its role in assessing NAC involvement remains underexplored.
Data Highlights
A retrospective study included 182 breast cancer cases (91 with pathological NAC involvement and 91 matched controls without NAC involvement) from a cohort of 641 cases. CE-CBBCT imaging was performed with two-phase contrast-enhanced scans. Imaging features assessed included asymmetric NAC enhancement, nipple retraction, periareolar skin thickening, suspicious calcifications, and tumor–nipple distance. Radiologists independently evaluated imaging blinded to pathology results.
Key Findings
CE-CBBCT demonstrated high diagnostic accuracy in detecting NAC involvement in early breast cancer.
Significant imaging predictors of NAC involvement included asymmetric NAC enhancement and nipple retraction on CE-CBBCT.
CE-CBBCT allows simultaneous assessment of microcalcifications and contrast enhancement without breast compression.
Propensity score matching controlled for confounders such as age, menopausal status, and tumor stage, strengthening the validity of findings.
CE-CBBCT may provide a non-invasive, rapid, and reliable imaging modality to guide surgical planning for NSM candidates.
Clinical Implications
CE-CBBCT can be integrated into preoperative breast cancer evaluation to improve detection of NAC involvement, thereby aiding in selecting appropriate candidates for nipple-sparing mastectomy. Its ability to provide detailed 3D imaging without compression and to assess both enhancement and calcifications may enhance diagnostic confidence. Clinicians should consider CE-CBBCT especially in patients contraindicated for MRI or when detailed NAC assessment is required.
Conclusion
Contrast-enhanced cone-beam breast CT shows promising diagnostic performance in assessing nipple–areolar complex involvement in early breast cancer, supporting its use as a valuable tool in preoperative evaluation and surgical planning.
References
Sun Yat-sen University Cancer Center Study 2019-2021 -- Efficacy of CE-CBBCT in NAC involvement
Regulatory Approvals -- CE-CBBCT by Chinese NMPA, US FDA, EU